Financial Regulation

A landmark partnership between Anthem and Ohio chambers marks 10 years, covering 94,000 people and reshaping affordable healthcare for small employers.

At the elite FiRe 2026 conference, Pattern Computer plans to unveil a 'hallucination-free' AI, promising a new era of scientific discovery and trust.

LANGLARA, a new Lantus biosimilar, gains FDA approval, promising more affordable diabetes care. But it faces a tough fight in a competitive market.

New AI tools create mortgage presentations in seconds, promising to level the playing field for loan officers while raising questions of trust and regulation.

Leaders in security, finance, and policy convene to address the urgent quantum threat to data, pushing post-quantum readiness to a top governance issue.

A new company emerges from Purdue Pharma's bankruptcy, owned by a non-profit and tasked with fighting the very opioid crisis its predecessor fueled.

AmLaw firm Phelps adds five lawyers from a former boutique, a strategic move to dominate the booming DFW financial services and litigation market.

Over 100 American clergy defend the Family Federation in Japan, framing a local legal battle over finances as a global fight for religious freedom.

Two cannabis giants unite as MM Brands taps StateHouse to scale its iconic Mary's Medicinals and DIXIE brands across the competitive California market.

Facing mounting losses, BayFirst Financial raises $80M and names a new CEO in a bold gambit to recapitalize and refocus on its Tampa Bay roots.

The biotech firm's new genomic intelligence platform aims to de-risk development by providing the first-ever benchmarks for chromosomal integrity.

Aequify's new AI platform automates complex data collection, promising to free up tax advisors for higher-value, year-round client guidance.

Hannover Re US names Kelly Rabin Chief Actuary, a strategic move leveraging her diverse insurtech and consulting background to drive innovation.

BsStrategy's latest platform update signals a major shift in AI finance, where robust infrastructure and risk control are eclipsing the hunt for magic algorithms.

PVP Labs' new drug offers potent pain relief without addiction risk. A landmark DEA ruling clears it as a non-controlled substance, set to reshape medicine.

With a 90% strike authorization, 10,000 nurses at Corewell Health East demand better staffing and wages, raising concerns for patient care.

Ottawa's new economic update promises relief from high costs and a crackdown on fraud, but critics question the price tag and long-term strategy.

South Korea approves its first homegrown CAR-T therapy, a landmark achievement offering new hope for lymphoma patients with impressive response rates.

The acquisition of Japan's Sygna by VerifyVASP marks a major consolidation in the Travel Rule market, promising a unified network for crypto firms.

A new report reveals how illegal streaming and downloads are funding drug trafficking and money laundering, urging a global response to this hidden threat.